logo
HomeStocksIOLCP

I

IOL Chemicals & Pharmaceuticals

IOLCP Share PriceHealthcare

194.31

-17.12 (-8.10%)loss
as on 11 Sep 2026 at 03:59 PM
views302
portfolio1.5K
analyst100% Buy
Overview
Pros & Cons
News
History
Fundamentals
Investment Returns
Technicals
Financials
Balance Sheet
Cash Flow
Corporate Actions
Peers

IOL Chemicals & Pharmaceuticals Share Price Today

Today IOL Chemicals & Pharmaceuticals opened at 210.51 while its previous close was at 211.43. In todays trading session IOLCP reached a high of 210.95 and low of 192.00. The average traded price for today is 200.06. The 50 DMA stands at 168.52 and 200 DMA is at 110.90. Looking at intraday trend, the stock is in Downtrend.

Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.

IOLCP Stock Performance

Markets Today

High

210.95

Low

192.00

Open at

210.51

Prev Close

211.43

Volumes

51,29,124

Avg Price

200.06

Lower Circuit

155.45

Upper Circuit

233.17

Last Traded Details

Quantity

33

Time

15:59:11

Price Movement

192.00210.95
1.20%Loss
down side
up side
7.89%Profit

Historical Performance

3 M High

219.04

3 M Low

123.20

1 Yr High

219.04

1 Yr Low

67.19

3 Yr High

219.04

3 Yr Low

57.50

5 Yr High

219.04

5 Yr Low

54.56

1-Year Performance

67.19219.04
189.19%Loss
down side
up side
11.29%Profit

IOLCP Pros and Cons

byfuzz AI

Consolidated revenue grew from ₹551.7 Cr in Q1 FY26 to ₹756.3 Cr in Q1 FY27, driving strong top-line expansion.

Pharmaceuticals EBIT climbed from ₹34.5 Cr in Q3 FY26 to ₹68.8 Cr in Q1 FY27, signaling a strong segment turnaround.

Consolidated EBITDA margin expanded from 10.7% in Q3 FY26 to 14.6% in Q1 FY27, reflecting restored pricing power.

Consolidated EPS rebounded from ₹0.70 in Q3 FY26 to ₹2.20 in Q1 FY27, driving shareholder value.

Consolidated cost of materials consumed surged from ₹356.7 Cr in Q3 FY26 to ₹506.8 Cr in Q1 FY27, signaling sharp input cost inflation.

Consolidated other expenses jumped from ₹83.7 Cr in Q3 FY26 to ₹103.5 Cr in Q1 FY27, signaling rising operational overheads.

Consolidated inventory changes swung from 25.6 Cr in Q3 FY26 to -29.5 Cr in Q1 FY27, signaling active stock drawdown.

Consolidated employee benefits expense rose from ₹56.9 Cr in Q3 FY26 to ₹71.2 Cr in Q1 FY27, indicating ongoing workforce expansion.

fuzz Insights
Positive

Revenue outpaced rising material costs to protect profit margins.

Positive

Stable pharma earnings cushion volatile chemicals performance.

Positive

Tighter working capital unlocked operating cash flow.

Neutral

Pre-tax profits spiked then normalized while core operations grew steadily.

Neutral

Rising overheads are dampening operating profit growth.

Neutral

Consolidated growth relies heavily on pharma sales.

IOLCP Analyst Rating

Buy

Analysts have suggested that investors can Buy this Stock

- By Refinitiv from 1 analysts

Buy

100%

Hold

0%

Sell

0%

Get forecast for Price, ROA & ROE based on analyst ratings.

Get Forecast

IOLCP Share Price History

IOLCP Fundamentals

Company Valuation

Market Cap (₹ Cr.)

5,704

PE Ratio

36.90

PB Ratio

3.45

Dividend Yield

0.47%

ROE

7.65%

ROCE

10.49%

Book Value (₹)

61.27

Face Value (₹)

2.00

Analyse IOLCP with 12+ custom fundamentals and financial ratios.

Analyse Now

Share Holding Pattern

Held ByJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
52.62%52.62%52.62%57.48%62.28%
Domestic Institutional Investors (DII)
0.02%0.04%0.03%0.02%0.43%
Foreign Institutional Investors (FII)
2.59%2.25%2.08%1.72%4.87%
Public Investors
30.22%29.97%30.51%31.03%26.95%
Government
0.00%0.00%0.00%0.00%0.00%

Promoters

Domestic Institutional Investors (DII)

Foreign Institutional Investors (FII)

Public Investors

Government

IOL Chemicals & Pharmaceuticals Return Calculator

You have invested
Investment Period

Current value of ₹1,00,000 invested 5 years ago, as on today

0

Gain

1,00,000 (91.46%)

Note: Past profits do not guarantee future returns.

IOLCP Investment Returns

1 Week

1 Month

3 Months

6 Months

9 Months

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.

IOLCP Technicals

Moving Averages

PeriodSimpleSignal
5-SMA208.94Bullish
10-SMA200.86Bullish
20-SMA185.27Bullish
50-SMA168.52Bullish
100-SMA143.45Bullish
200-SMA110.90Bullish

Technical Indicators

IndicatorValueAction
RSI(14)74.69Neutral
ATR(14)10.08Less Volatile
STOCH(9,6)80.41Overbought
STOCH RSI(14)80.65Overbought
MACD(12,26)2.19Bullish
ADX(14)41.58Strong Trend

Summary of Technical Indicators for IOLCP

Margin on IOLCP

Order TypeMargin to PayLeverageQuantityTrade ValueMargin AmountActions

*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).

IOLCP Financials Summary

View By:
Revenue
EBITDA
Net Profit
EPS
Revenue

In Crores

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
559574586621764

IOLCP Financials

View by

Income Statement

In Cr

Quarterly StatementJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
559574586621764
Expenses490511534527653
70645194112
Operating Profit62574693104
Operating Profit Margin %11%10%8%15%14%
Other Income77528
Interest44434
Depreciation2020202021
4641287187
Tax %25%26%25%25%26%
Net Profit3430215364
EPS11122

Balance Sheet

In Cr

Yearly Balance SheetMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
1,9622,0222,2442,3822,587
Fixed Assets5617529331,1711,182
Current Assets1,0819201,1201,1511,228
Capital Work in Progress105901012296
Investments220202121
Other Assets1,2941,1611,1901,1691,289
1,9622,0222,2442,3822,587
Current Liabilities513456560610690
Non Current Liabilities5758738598
1,3921,5081,6121,6881,799
Reserve & Surplus1,3341,4491,5531,6291,740
Share Capital5959595959
Minority Interest00000

Cash Flow

In Cr

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Activities93122290179214
Investing Activities-121-120-191-154-198
Financing Activities-2-4-9346-29
Net Cash Flow-29-2671-13

Corporate Actions

DateCorporate ActionInformation
10th Aug 2026, Monday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q1 FY 26-27 Results
info
20th May 2026, Wednesday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q4 FY 26-27 Results
info
17th Feb 2026, Tuesday
DIVIDENDDividend
Interim Dividend of ₹1/share
11th Feb 2026, Wednesday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q3 FY 25-26 Results
info
11th Nov 2025, Tuesday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q2 FY 25-26 Results
info

The above dates are ex-dates.

Check IOLCP latest Company Filings, Investor Presentation & Conference Call details.

Read Now

IOLCP Revenue Growth

All values are in Crores

Revenue

Profit

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2025-262,340
11.36% profit
138
36.36% profit
FY 2024-252,102
-2.83% Loss
101
-25.42% Loss
FY 2023-242,163
-3.56% Loss
135
-3.26% Loss

NSE Indices Today

Index NamePrice

FAQs on IOLCP

IOL Chemicals & Pharmaceuticals share price as of today is ₹ 194.31 as on 11 Sep 2026 at 03:59 PM.
The 52W high of IOL Chemicals & Pharmaceuticals is ₹ 219.04 and 52W low is ₹ 67.19 as of 11 Sep 2026 at 15:59.
The past returns of IOL Chemicals & Pharmaceuticals share are -
  • Past 1 year: 71.11%
  • Past 3 years: 100.46%
  • Past 5 years: 91.46%
The PE and PB ratio of IOL Chemicals & Pharmaceuticals stands at 36.90 and 3.45 respectively as on 11 Sep 2026 at 15:59.
The EPS of IOL Chemicals & Pharmaceuticals is 2.19 for the quarter ended Jun 2026 and 4.69 for the financial year 2025-26.
The shareholding pattern of IOL Chemicals & Pharmaceuticals is as follows:
  • DIIs - 0.43%
  • FII - 4.87%
  • Promoters - 62.28%
  • Public Investors 26.95%
  • Goverenment - 0.00%
Yes, you can buy shares of IOL Chemicals & Pharmaceuticals online by opening Demat account with Dhan.
If you are a Dhan user already, you can buy IOL Chemicals & Pharmaceuticals stocks from Dhan Trading App or Web Trading Platform. If you are new to Dhan follow the below steps:
  1. Download the Dhan App to Open a Demat Account
  2. Navigate to the “Money Tab”
  3. Add money to your account
  4. Search for IOL Chemicals & Pharmaceuticals share
  5. Tap on “Buy”
With Dhan you can start a daily, weekly or monthly SIP in IOL Chemicals & Pharmaceuticals.
You can easily buy the shares of IOL Chemicals & Pharmaceuticals even after the markets are closed using the After Market Order feature on Dhan Trading App.


Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2026 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services and works closely with Raise Partners across services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered & Corporate Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104, Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES/SMART ODR Portal: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances. You may refer the website https://scores.sebi.gov.in/ for more information. You may also download the SEBI Scores app to log a complaint Android: https://play.google.com store apps sebiscores iOS: https://apps.apple.com app sebiscores.


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. Issued in the interest of the investors.


Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account. Raise Securities Private Limited (Dhan) does not engage in proprietary trading on its own account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | Investor Charter for Research Analyst | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details | MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Grievances RA | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors | Master Circular for Online Dispute Resolution